Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice

Taube, Christian; Valipour, Arschang; Bayer, Valentina; Kondla, Anke; Marseille, A.; Medvedchikov, Alexey; Haaksma-Herczegh, Monika; Zehendner, Christoph M.

doi:10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3311

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, inhaled therapy with tiotropium/olodaterol FDC with the Respimat device also seems to be associated with improvements in the well-being of the subject. Moreover, patients reported a high satisfaction with the treatment with tiotropium/olodaterol FDC inhalation solution, inhaling from the Respimat device, and handling of the device as well, which further supports other studies in different countries and, in some cases, those that did not analyze patients with COPD exclusively [42,43].…”

Section: Discussionsupporting

confidence: 81%

Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy

et al. 2020

View full text Add to dashboard Cite

Introduction: Clinical studies have shown significant improvements in exercise capacity in patients with chronic obstructive pulmonary disease (COPD) who are treated with a tiotropium/ olodaterol fixed-dose combination (FDC). However, the effects of this treatment, which is administered in a single device, on physical functioning in a real-life setting of patients with COPD had not been fully determined.Methods: An open-label, observational study was conducted in 309 patients with COPD from 29 sites across Italy who received tiotropium/ olodaterol FDC for 6 weeks. Physical functioning was evaluated using the Physical Functioning Questionnaire (PF-10). The primary endpoint was the proportion of patients with therapeutic success, defined as a ten-point increase in the PF-10 score from the baseline visit. Secondary endpoints were absolute changes in PF-10 score from baseline visit, the patient's general condition assessed by the Physician's Global Evaluation (PGE) score, and patient satisfaction with treatment, inhaling and handling of the device. Results: According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) multimodality assessment, most patients were Digital Features To view digital features for this article go to

show abstract

Section: Discussionsupporting

confidence: 81%